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REGISTRY OF DOCTORS’ COMPETING INTERESTS
Problems with ABPI proposals to release data on
payments to doctors
Ben Goldacre research fellow
London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
Whitehead of the Association of the British Pharmaceutical
Industry (ABPI) says the drug industry will soon declare all
payments to doctors.1 2 There are several problems with his new
promises.
Firstly, industry has been promising such transparency for years,
without delivering. At the same time, the same companies are
campaigning against transparency in other areas.
Secondly, industry representatives now say—when directly
questioned about completeness—that EU privacy lawwill permit
individual doctors to opt out of having their payments declared.
Some of the most important data will still be hidden.
Thirdly, doctors’ potential conflicts of interest extend beyond
payments from drug companies to include payments from PR
firms, income from local healthcare providers, and more.
This is why we suggest that doctors should be obliged to declare
their own complete list of competing interests, ideally to the
General Medical Council.1
Greater transparency from the ABPI is still welcome. The
limited, incomplete dataset it provides could be merged with
other data sources to provide a more complete picture and help
identify gaps that may signal areas and individuals of greater
concern.
Unfortunately the ABPI currently plans to release this
information through its own website. It says it wants to provide
a “one stop” service with web pages for patients wishing to find
out about their doctors. In reality, this will mean that a flawed
and incomplete dataset is presented to the public, as if complete,
under editorial control of industry, with better uses unnecessarily
obstructed.
The ABPI could release this information as structured open
data, in open formats, freely available for reuse by third parties,
as is now standard practice in government and other sectors.3
Its data could then be aggregated and matched against other
sources to produce genuinely useful information and insights.
The ABPI should reconsider.
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Full response at: www.bmj.com/content/348/bmj.g236/rr/682926.
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